Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 4 Comparison of anthropometric and biochemical measurements in the dysglycemic patient group and the control group

From: Plasma and urine metabolic profiles are reflective of altered beta-oxidation in non-diabetic obese subjects and patients with type 2 diabetes mellitus

  Dysglycemic/obese (n = 6 ) (X ± SD) Dysglycemic/ offspring (n = 5) (X ± SD) Control (n = 19) (X ± SD)
Age 53.0 ± 7.66* 46.6 ± 12.0* 24.3 ± 3.7
BMI 33.2 ± 8.28* 33.8 ± 6.7* 22.8 ± 1.4
Waist cm 99.9 ± 14.7* 109.0 ± 20.9* 70 ± 7.7
Hip cm 107.2 ± 8.7* 116.2 ± 24.5 95 ± 7.7
% Lean mass 66.8 ± 7.9 62.8 ± 15.1 74.3 ± 9.9
Total weight 87.2 ± 21.8* 95.8 ± 26.0* 63.1 ± 9.2
Glucose O´ 97.2 ± 16.5 100.6 ± 8.8* 83.9 ± 12.5
Glucose 30´ 169.7 ± 35.3* 177 ± 39.91 131 ± 30.9
Glucose 60´ 182.8 ± 55.0* 196.2 ± 23.8* 113.9 ± 25.3
Glucose 90´ 171.0 ± 42.8* 198.0 ± 38.5* 109.27 ± 33.33
Glucose 120´ 150.0 ± 45.9* 165.0 ± 20.92* 94.9 ± 21.7
Insulin 0´ 16.0 ± 9.6 12.6 ± 5.6 7.3 ± 2.0
Insulin 30´ 87.4 ± 42.6 98.7 ± 54.3 56.7 ± 24.6
Insulin 60´ 153.2 ± 135.6 126.2 ± 56.4* 57.9 ± 36.2
Insulin 90´ 130.3 ± 77.3 131.7 ± 59.0* 54.8 ± 35.8
Insulin 120´ 132.2 ± 84.1* 109.1 ± 46.0* 41.4 ± 37.0
Matsuda index 2.9 ± 2.1* 2.4 ± 1.0* 6.2 ± 1.8
HOMA IR 3.5 ± 1.5* 3.2 ± 1.5 1.5 ± 0.4
Free fatty acids 0.5 ± 0.3 0.7 ± 0.2 0.5 ± 0.3
Uric Acid 6.4 ± 1.4 7.12 ± 0.6* 5.2 ± 1.0
Serum Creatinine 0.9 ± 0.3 0.9 ± 0.2 0.8 ± 0.15
Cholesterol 234.5 ± 22.7* 180.8 ± 21.5 200.6 ± 39.6
AST 16.5 ± 7.6 18.2 ± 10.8 10.4 ± 2.0
ALT 12.0 ± 3.2* 19.4 ± 9.9 8.2 ± 2.6
Triacylglycerol 204.8 ± 80.0* 283.6 ± 177.3 110.6 ± 71.2
C4 0.18 ± 0.08 0.25 ± 0.13 0.18 ± 0.08
C2 8.4 ± 1.6 9.8 ± 1.05 8.7 ± 1.6
C16 0.74 ± 0.17 0.85 ± 0.14* 0.67 ± 0.17
C 14:2 0.03 ± 0.02* 0.05 ± 0.03 0.06 ± 0.3
  1. *P value: <0.05.
  2. NOTE: Parameters in bold were significant.
Back to article page